Extrapulmonary sarcoidosis during antiviral therapy for chronic hepatitis C

  • Authors: Gromova N.I.1, Lopatkina TN2, Gromova NI3, Lopatkina TN4
  • Affiliations:
    1. ФГУ Поликлиника № 1 Управления делами Президента РФ, Москва
    2. Клиника нефрологии, внутренних и профессиональных болезней им. Е. М. Тареева ГОУ ВПО Первый Мсковский государственный медицинский университет им. И. М. Сеченова
    3. Polyclinic One, Department for Presidential Affairs of the Russian Federation, Moscow
    4. Ye. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases, I. M. Sechenov Moscow Medical Academy
  • Issue: Vol 15, No 6 (2010)
  • Pages: 42-44
  • Section: Articles
  • URL: https://journals.rcsi.science/1560-9529/article/view/40491
  • DOI: https://doi.org/10.17816/EID40491
  • ID: 40491

Cite item

Full Text

Abstract

The spectrum of adverse reactions caused by combined interferon therapy includes the development of autoimmune diseases, including sarcoidosis. Extrapulmonary sarcoidosis is its rare form. The paper describes a case of extrapulmonary sarcoidosis in a young woman at 28 weeks of combined interferon therapy for chronic hepatitis C 1b genotype. Corticosteroid therapy led to remission with the retention of a sustained virological response to antiviral therapy.

About the authors

Natal'ya Ivanovna Gromova

ФГУ Поликлиника № 1 Управления делами Президента РФ, Москва

Email: gromovamail@mail.ru
канд. мед. наук, зав. отд. инф. заболеваний; ФГУ Поликлиника № 1 Управления делами Президента РФ, Москва

T N Lopatkina

Клиника нефрологии, внутренних и профессиональных болезней им. Е. М. Тареева ГОУ ВПО Первый Мсковский государственный медицинский университет им. И. М. Сеченова

Клиника нефрологии, внутренних и профессиональных болезней им. Е. М. Тареева ГОУ ВПО Первый Мсковский государственный медицинский университет им. И. М. Сеченова

N I Gromova

Polyclinic One, Department for Presidential Affairs of the Russian Federation, Moscow

Polyclinic One, Department for Presidential Affairs of the Russian Federation, Moscow

T N Lopatkina

Ye. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases, I. M. Sechenov Moscow Medical Academy

Ye. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases, I. M. Sechenov Moscow Medical Academy

References

  1. Анисимов Л. А. Поражение печени при саркоидозе: Автореф. дис. ... канд. мед. наук. - М., 1987.
  2. Bolukbas C., Bolukbas F. F., Kebdir T. et al. Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C - a case report and review of the literature // Acta Gastroenterol. Belg. - 2005. - Vol. 68, N 4. - P. 432-434.
  3. Cacoub P., Sbai A., Frances C. et al. Systemic sarcoidosis during interferon-alpha therapy for chronic hepatitis C virus infection // Gastroenterol. Clin. Biol. - 2000. - Vol. 24. - P. 364- 366.
  4. Celik G., Sen E., Ulger A. F. et al. Sarcoidosis caused by interferon therapy // Respirology. - 2005. - Vol. 10, N 4. - P. 535-540.
  5. Goncales F. L. Jr. et al. Weight-based combination therapy with peginterferon alpha-2b and ribavirin for Naive, relapser and non-responder patients with chronic hepatitis C // Braz. J. Infect. Dis. - 2006. - Vol. 10, N 5. - P. 311-316.
  6. Hoffmann R. M., Jung M.-C., Motz R. et al. Sarcoidosis associated with interferon-α therapy for chronic hepatitis C // J. Hepatol. - 1998. - Vol. 28. - P. 1058-1063.
  7. Hurst E. A., Mauro T. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature // Arch. Dermatol. - 2005. - Vol. 141, N 7. - P. 865-868.
  8. Michavila I. A., Sanchez M. M., Ronchel P. et al. Sarcoidosis following combined ribavirin and interferon therapy: a case report and review of the literature // Arch. Bronconeumol. - 2004. - Vol. 40. - P. 45-49.
  9. Perez-Alvarez R., Perez-Lopez R., Lombrana J. L. et al. Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine // J. Viral Hepatit. - 2002. - Vol. 9. - P. 75-79.
  10. Ramos-Casals M., Mana J., Nardi N. et al. Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases // Medicine (Baltimore). - 2005. - Vol. 84, N 2. - P. 69- 80.
  11. Schiff E. R. Emerging strategies for pegylated interferon combination therapy // Nat. Clin. Pract. Gastroenterol. Hepatol. - 2007. - Vol. 4, Suppl. 1. - P. S17-S21.
  12. Tae-Hun Kim, Jong-Eun Joo. Spontaneous resolution of systemic sarcoidosis in a patient with chronic hepatitis C without interferon therapy // Wld J. Gastroenterol. - 2006. - Vol. 12. - P. 150-153.
  13. Tortorella C., Napoli N., Panella E. et al. Asymptomatic systemic sarcoidosis arising 5 years after IFN-alpha treatment for chronic hepatitis C: a new challenge for clinicans // J. Interferon Cytokine Res. - 2004. - Vol. 24, N 11. - P. 655-658.
  14. Yamada S., Mine S., Fujisaki T. et al. Hepatic sarcoidosis assosiated with chronic hepatitis C // J. Gastroenterol. - 2002. - Vol. 37. - P. 564-570.

Copyright (c) 2010 Eco-vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies